Forecasting & Growth
Where the business is going and what to do next.
Revenue forecast (next 30d)
₦346.0M
+8.8% vs current MTD
Gross profit forecast
₦104.8M
30.3% margin held
Stock pressure
Medium
₦42M in restocks needed
Expansion readiness
72 / 100
4th branch feasible Q2
Revenue & profit outlook
6-month projectionJulAugSepOctNovDec
Revenue ₦M Profit ₦M
Demand forecast
Beverages88 idx
Groceries82 idx
Pharmacy74 idx
Personal Care58 idx
Household44 idx
Branch growth readiness
Wuse 288/100
Gwarinpa74/100
Apo Pharmacy66/100
Branch expansion recommendation
Executive board Recommended: Open 4th branch — Lekki Phase 1
Model suggests ₦58M–72M revenue potential in month 6, break-even at month 9, based on Wuse 2 & Gwarinpa performance curves.
Setup cost
₦86M
Payback
14 mo
Risk score
Medium
What-if scenarios
Impact modelinglow risk
Add 1 more POS lane to Wuse 2
Uplift+₦6.4M / mo
ROI3.2x
low risk
Improve Gwarinpa cash control
Uplift−₦840k leakage
ROIimmediate
med risk
Expand Apo pharmacy category
Uplift+₦4.1M / mo
ROI2.4x
low risk
Reduce dead stock by 12%
Uplift+₦1.4M released
ROIimmediate
med risk
Increase loyalty retention +8%
Uplift+₦8.6M / mo
ROI4.1x
Risk-adjusted forecast
₦328.0M
Downside 5%
Best-case forecast
₦374.0M
Upside 8.1%
Opportunity pipeline
₦22.8M / mo
5 initiatives